
Thomas Barnet
Journalist
Lindt, Eurofins Cerep, Lotus Bakeries... European stocks with eye-watering share prices
The release of Lindt's results, poorly received, no less, is an opportunity to take a look at Western European listed stocks whose prices are extremely high. The Swiss chocolatier's main share trades around CHF 115,000, or roughly 5 years of the median French net salary.
March 10, 2026 at 05:13 am
Equinor Announces Two Oil and Gas Discoveries in the North Sea
Equinor has discovered oil in the Troll area and gas with condensate in the Sleipner area, two finds deemed commercially viable and located near already well-developed infrastructure for exports to Europe.
March 10, 2026 at 03:51 am
Vaziva launches €8 million convertible bond issue
The company specializing in employee benefit cards is set to raise funds through a private placement of bonds convertible into new shares (OCA) for a maximum amount of €8 million. The operation is intended to support the company's growth strategy and finance its European rollout.
March 09, 2026 at 01:26 pm
FDA grants Orphan Drug Designation to Genfit's NTZ for ACLF
The FDA has granted Orphan Drug Designation (ODD) to nitazoxanide (NTZ), developed by Genfit for the treatment of acute-on-chronic liver failure (ACLF), a severe condition with no currently approved therapies.
March 09, 2026 at 01:14 pm
Why TotalEnergies is failing to capitalize on surging oil prices
Despite oil prices jumping by over 50% in just ten days, TotalEnergies shares remain roughly where they were at the end of February. This muted reaction is largely due to two primary factors.
March 09, 2026 at 06:11 am
Why TotalEnergies is failing to capitalize on surging oil prices
Despite oil prices jumping more than 50% in ten days, TotalEnergies shares remain roughly where they were at the end of February. This muted reaction can be attributed to two primary factors.
March 09, 2026 at 05:37 am

Robertet Brings Biotech Innovation to Its Flavors and Fragrances
The Grasse-based group is set to strengthen its relationship with Italian biotechnology company Aethera Biotech by entering into a capital agreement that will see a gradual increase in stake within a joint venture, rolled out in two phases over three years.
March 06, 2026 at 05:16 am
Discover our authors
Chief Editor
Journalist
Analyst
Analyst
Junior Analyst
- Stock Market
- Our authors
- Thomas Barnet


















